Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166630 · ClinicalTrials.gov registry record · NA
Diagnosing Intensive Care Unit (ICU) Acquired Weakness
A NA study of ICU Acquired Weakness, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT04166630: Completed NA study of ICU Acquired Weakness, sponsored by Emory University.
NCT04166630 is a NA study of ICU Acquired Weakness that has completed, run by Emory University. The registered enrollment target is 22 participants, below the 2,109-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04166630, a NA study of ICU Acquired Weakness, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal muscle will be stimulated with an FDA approved clinical electrical stimulator and accelerations will be passively recorded with an accelerometer.
Primary Outcome
The highest acceleration over a single muscle twitch will be used as the peak acceleration. Peak acceleration will be measured in acceleration in number of times gravity (g). Higher twitch acceleration is a better response.
Conditions Studied
Interventions
- DEVICE Clinical Electrical Stimulator
Study Locations (1)
Georgia
- Grady Health System - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
What the finished NCT04166630 record still lists
NCT04166630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 2,109-participant average among 4 other ICU Acquired Weakness trials with a reported enrollment target (99% lower).
The record links to 1 condition, with ICU Acquired Weakness appearing as the primary indexed condition, and to 1 intervention - of which Clinical Electrical Stimulator is the first listed.
NCT04166630 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04166630 about?
NCT04166630 is a clinical study titled "Diagnosing Intensive Care Unit (ICU) Acquired Weakness". The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal mus...
What is the current status of trial NCT04166630?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-02-02. Estimated completion is 2021-06-11.
What conditions does trial NCT04166630 study?
This clinical trial studies the following conditions: ICU Acquired Weakness.
What interventions are being tested in trial NCT04166630?
The interventions under investigation include: Clinical Electrical Stimulator (DEVICE).
Who is sponsoring clinical trial NCT04166630?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04166630 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ICU Acquired Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Economic & Staffing Strategies in the ICU
RECRUITING · NA
-
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
RECRUITING · NA
-
Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers
COMPLETED · NA
-
Muscle Recovery After Critical Illness
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI